US poll backs bigger gov’t role on drug prices

	Tweet

Nearly two-thirds of people want the U.S. government more involved in limiting the price of prescription drugs, according to a survey released on Thursday by a nonprofit health research group.

Sixty-five percent of the 1,200 adults polled said they want more government regulation of drug prices, while 14 percent said there was too much regulation.

Forty-six percent said they would back more price regulation even if it might lead to less research and development, as drug makers argue.

The federal Medicare program will implement broad prescription drug coverage starting next January. Medicare officials are forbidden by law from negotiating drug prices with the manufacturers. Other government agencies such as the Defense Department already negotiate prices.

The telephone poll was conducted during the first week of February by the Kaiser Family Foundation, a nonprofit health research organization.

Half of those surveyed reported taking a prescription drug daily.

Despite recent controversies about drug side effects, 77 percent of people polled said they were “very” or “somewhat” confident in the Food and Drug Administration’s ability to ensure drug safety.

The poll’s margin of error was plus or minus 3 percentage points.

RELATED STORIES:
New UTHealth Trial Aimed at Helping Pregnant Women Stop Smoking   Statins may cut stroke disability, deaths   U.S. FDA looking to improve drug safety monitoring   Merck rushed unsafe Vioxx to market, lawyer argues   India drug firm pulls antiretrovirals from WHO list   US Medicare offers revamped coverage final rules   Banning a drug carrying some risk is not always best prescription   Caraco reports U.S. FDA approval to market generic glucotrol   U.S. Tamiflu demand spikes amid bird flu fears   FDA drafts new guidance to industry for group of medical tests   Glaxo hopes for pandemic flu vaccine by yr-end   Cialis impotence drug returns to Super Bowl

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]